DataMEDS AI, Inc. (NASDAQ: MEDS) has completed the acquisition of Helomics Corporation, an artificial intelligence cancer diagnostics laboratory, from Axe ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions